Search

everythinglearnresearchcommunity

for

Search:↓

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

PRP treatment may help with alopecia areata, especially in newer cases.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

New instruments were introduced to make hair transplantation surgery more precise and improve graft survival.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

AB+ blood group is more common in alopecia areata patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Higher CRBP1 levels are linked to more severe alopecia areata.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Better documentation of alopecia areata in Black individuals is needed to improve diagnosis.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.